https://scholars.lib.ntu.edu.tw/handle/123456789/596700
標題: | Intravenous tissue plasminogen activator for acute ischemic stroke in patients with renal dysfunction | 作者: | Wang I.-K. Yen T.-H. CHIH-HAO CHEN Hsu S.-P. Sun Y. Lien L.-M. Chang W.-L. Lai T.-C. Chen P.-L. Chen C.-C. Huang P.-H. Lin C.-H. Su Y.-C. Lin M.-C. Li C.-Y. Sung F.-C. Hsu C.Y. Taiwan Stroke Registry Investigators |
公開日期: | 2022 | 卷: | 114 | 期: | 12 | 起(迄)頁: | 848-856 | 來源出版物: | QJM : monthly journal of the Association of Physicians | 摘要: | OBJECTIVE: This study used the Taiwan Stroke Registry data to evaluate the efficacy and safety of intravenous tissue plasminogen activator (tPA) in treating acute ischemic stroke in patients with renal dysfunction. DESIGN: We identified 3525 ischemic stro |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85123649413&doi=10.1093%2fqjmed%2fhcaa237&partnerID=40&md5=0dad4da7d6933f01ca9d07a4e33d53cb https://scholars.lib.ntu.edu.tw/handle/123456789/596700 |
ISSN: | 14602393 | DOI: | 10.1093/qjmed/hcaa237 | SDG/關鍵字: | fibrinolytic agent; tissue plasminogen activator; brain ischemia; cerebrovascular accident; complication; fibrinolytic therapy; human; kidney disease; retrospective study; treatment outcome; Brain Ischemia; Fibrinolytic Agents; Humans; Ischemic Stroke; Ki |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。